Caveolin-1 in Cardiovascular Disease: A Double-Edged Sword.
Division of Endocrinology, Diabetes and Metabolism, Department of Medicine and Thomas W. and Joan F. Burns Center for Diabetes and Cardiovascular Research, University of Missouri, Columbia, MO Harry S. Truman Memorial Veterans' Hospital, Columbia, MO.
Guanghong
G
Jia
Division of Endocrinology, Diabetes and Metabolism, Department of Medicine and Thomas W. and Joan F. Burns Center for Diabetes and Cardiovascular Research, University of Missouri, Columbia, MO Harry S. Truman Memorial Veterans' Hospital, Columbia, MO Department of Medical Pharmacology and Physiology, University of Missouri, Columbia, MO sowersj@health.missouri.edu.
James R
JR
Sowers
D000818:Animals; D050197:Atherosclerosis / Q000378:metabolism*; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism*; D003925:Diabetic Angiopathies / Q000378:metabolism*; D042783:Endothelial Cells / Q000378:metabolism*; D004730:Endothelium, Vascular / Q000378:metabolism*; D006801:Humans; D008297:Male; D052250:Nitric Oxide Synthase Type III / Q000378:metabolism*
D052250:Nitric Oxide Synthase Type III